We are building a solid-state nanopore device that can count individual SARS-CoV-2 virions in diverse bodily fluids without reagents or a cold chain.

We're a YC-backed nanotech-for-biotech startup with four full-time employees currently, 3 of whom are cohabitating in quarantine with access to a prototype lab.

We are close to a manufacturable first prototype that we expect to be useful in detecting SARS-CoV-2 by June/July, with turnkey usability by the end of the summer.

This shows some of our early data (from more than a year ago) as well as the first minute of our YC Demo day pitch. https://drive.google.com/file/d/16tXZ0VyN3z33c0Idiw63ko_cwfcF-z3f/view

Please inquire for specific ways in which you can help. Founder has experience managing large teams of scientists and engineers, and if you have any of the relevant skills we can make good use of you.